Physiological Effects of Creatine Supplementation in Active Males (NB4)

January 2, 2017 updated by: Texas A&M University

Effects of 28 Days of Different Forms of Creatine Supplementation on Muscle Creatine, Body Composition and Exercise Performance in Recreationally Active Males

This study was designed to examine how different forms of creatine impact active males.

Study Overview

Detailed Description

This study examined the effects of different formulations of creatine nitrate on muscle creatine content, body composition, anaerobic exercise capacity, bench press performance and clinical chemistry panels in recreationally active males.

Study Type

Interventional

Enrollment (Actual)

48

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 38 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • participants are apparently healthy and recreationally active males between the ages of 18 and 40;
  • participants will need to have at least six months immediate prior history of resistance training on the bench press and leg press or squat;

Exclusion Criteria:

  • participants have a history of treatment for metabolic disease (i.e., diabetes), hypertension, hypotension, thyroid disease, arrhythmias and/or cardiovascular disease;
  • participants are currently using prescription medications;
  • participants have a history of smoking;
  • participants drink excessively (i.e., 12 drinks per week or more);
  • participants have a recent history of creatine supplementation within six weeks of the start of supplementation;

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Creatine monohydrate
Creatine monohydrate (6.0 g.) + dextrose (0.5 g.)
Creatine monohydrate (6.0 g) + dextrose (0.5 g)
Active Comparator: Creatine nitrate
Creatine nitrate (5.0 g. creatine monohydrate + 1.5 g. creatine nitrate that provides 1.0 g. of creatine and 0.5 g. nitrate in 2:1 ratio).
Creatine nitrate (5.0 g creatine monohydrate + 1.5 g. creatine nitrate that provides 1.0 g. of creatine and 0.5 g. nitrate in 2:1 ratio)
Placebo Comparator: Placebo
6.5 g. dextrose
Placebo (6.5 g dextrose)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Effects of 28 Days of Different Forms of Creatine Supplementation on Body Water
Time Frame: 28 Days
Assessing Body Water through Bioelectrical Impedance Analysis (BIA)
28 Days
Effects of 28 Days of Different Forms of Creatine Supplementation on Body Composition
Time Frame: 28 Days
Assessing Body Compositing through Dual-Energy X-Ray Absorptiometry (DXA)
28 Days
Effects of 28 Days of Different Forms of Creatine Supplementation on intramuscular creatine
Time Frame: 28 Days
Assessing intramuscular creatine using standard spectrophotometric methods using a microplate spectrophotometer
28 Days
Effects of 28 Days of Different Forms of Creatine Supplementation on intramuscular phosphocreatine
Time Frame: 28 Days
Assessing intramuscular phosphocreatine using standard spectrophotometric methods using a microplate spectrophotometer
28 Days
Effects of 28 Days of Different Forms of Creatine Supplementation on intramuscular ATP
Time Frame: 28 Days
Assessing intramuscular Adenosine Triphosphate (ATP) using standard spectrophotometric methods using a microplate spectrophotometer
28 Days
Effects of 28 Days of Different Forms of Creatine Supplementation on muscular strength
Time Frame: 28 Days
Assessing muscular strength through 1 Repetition Maximum (RM) testing
28 Days
Effects of 28 Days of Different Forms of Creatine Supplementation on muscular endurance
Time Frame: 28 Days
Assessing muscular endurance through repetition to failure testing
28 Days
Effects of 28 Days of Different Forms of Creatine Supplementation on anaerobic capacity
Time Frame: 28 Days
Assessing anaerobic capacity through 6 x 6 second sprints followed by a 30 second sprint on a Wingate bicycle ergometer
28 Days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Effects of 28 Days of Different Forms of Creatine Supplementation on training volume (weight lifted x number of repetitions x number of sets)
Time Frame: 28 Days
Assessing training volume using a calculator
28 Days
Effects of 28 Days of Different Forms of Creatine Supplementation on self-reported side effects
Time Frame: 28 Days
Assessing self-reported side effects using a side effects questionnaire
28 Days
Effects of 28 Days of Different Forms of Creatine Supplementation on blood
Time Frame: 28 Days
Measure standard clinical chemistry panels in the blood to evaluate safety
28 Days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Richard B Kreider, PhD, Texas A&M University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2014

Primary Completion (Actual)

December 1, 2014

Study Completion (Actual)

December 1, 2014

Study Registration Dates

First Submitted

December 14, 2016

First Submitted That Met QC Criteria

December 22, 2016

First Posted (Estimate)

December 28, 2016

Study Record Updates

Last Update Posted (Estimate)

January 4, 2017

Last Update Submitted That Met QC Criteria

January 2, 2017

Last Verified

January 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • IRB2014-0503FX

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dietary Supplementation

Clinical Trials on Placebo

3
Subscribe